The market has been high on Fluidigm Corporation (FLDM) stock recently. FLDM gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.
Fluidigm Corporation has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on FLDM!
What is Stock Sentiment?
In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.
Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive.
InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend.
Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .
What's Happening With FLDM Stock Today?
Fluidigm Corporation (FLDM) stock is up 2.68% while the S&P 500 is down -2.35% as of 9:56 AM on Tuesday, Jan 25. FLDM has gained $0.08 from the previous closing price of $2.98 on volume of 207,255 shares. Over the past year the S&P 500 has gained 11.70% while FLDM is down -54.80%. FLDM lost -$0.90 per share in the over the last 12 months.
To see InvestorsObserver's Sentiment Score for Fluidigm Corporation click here.
More About Fluidigm Corporation
Fluidigm Corp manufactures life science tools focused on the analysis of single cells and industrial applications of genomics. These tools are based on microfluidics and mass cytometry technologies. It sells instruments and consumables, including integrated fluidic circuits, assays, and reagents. Slightly more than half of the firm's revenue comes from the sale of Consumables. Fluidigm primarily sells its products to academic institutions, clinical laboratories, and biopharmaceutical companies. The majority of revenue is generated in the United States followed by EMEA and Asia-Pacific.
Click Here to get the full Stock Report for Fluidigm Corporation stock.